⌘K

Vida Ventures logo

Vida Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series B

Candid Therapeutics logo
Candid Therapeutics

Biotechnology • Autoimmune therapies

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article
Avalyn Pharma logo
Avalyn Pharma

Biopharmaceutical • Respiratory Diseases

Perceptive Xontogeny Venture Funds logo
Wellington Management logo
Vida Ventures logo
T. Rowe Price Associates logo

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Series C
$175M
09/27/2023
Article
ReCode Therapeutics logo
ReCode Therapeutics

Genetic Medicines • MRNA Therapeutics

Bioluminescence Ventures logo
Solasta Ventures logo
Sanofi Ventures logo
Pfizer Ventures logo

ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.

Series B
$50M
09/19/2023
Article